The question “am I a candidate for EVO ICL?” is one of the most important questions a person with nearsightedness or astigmatism can ask before choosing a vision correction procedure. EVO ICL, short for Implantable Collamer Lens, is an additive lens procedure that may provide sharp, clear vision for patients who are not ideal candidates for laser-based procedures. At Eye Care Physicians & Surgeons of New Jersey, our board-certified ophthalmologists offer personalized evaluations to help patients in Haddonfield, NJ, and the surrounding communities determine whether EVO ICL aligns with their prescription, anatomy, and lifestyle. This guide answers the most common questions prospective patients ask before scheduling a consultation.
Contact Eye Care Physicians & Surgeons of New Jersey to schedule your EVO ICL candidacy evaluation.
EVO ICL is an FDA-approved implantable lens designed to correct moderate to severe myopia (nearsightedness), with or without astigmatism. Unlike LASIK, EVO ICL does not remove corneal tissue. Instead, the surgeon places a thin, biocompatible Collamer lens between the natural lens and the iris, where it remains permanently unless removal is chosen. Collamer, a material derived partly from collagen, is designed to be compatible with the eye’s natural environment. Patients asking “am I a candidate for EVO ICL?” often appreciate that the lens is additive rather than subtractive, preserving the natural corneal structure.
EVO ICL works by adding a corrective lens inside the eye rather than reshaping the cornea. The implanted lens works alongside the eye’s natural lens to focus incoming light precisely onto the retina, which may produce sharper visual clarity for patients with high prescriptions. The procedure is performed on an outpatient basis and typically takes about 20 to 30 minutes per eye. Many patients notice improved vision within the first day following the procedure, though individual healing timelines vary.
EVO ICL is FDA-approved for the correction of myopia ranging from -3.0 to -20.0 diopters and may also address astigmatism. It is particularly relevant for patients whose prescriptions fall outside the range suitable for LASIK or PRK. Patients with thin corneas, large pupils, or dry eye concerns that might limit candidacy for laser procedures may still be candidates for EVO ICL. If you have questions about astigmatism and how it affects your vision correction options, our team can review your full prescription profile at your evaluation.
Determining whether you are a candidate for EVO ICL requires a comprehensive eye examination. General candidacy indicators include being between 21 and 45 years of age, having a stable prescription for at least one year, having adequate anterior chamber depth, and not having a history of certain eye conditions such as uncontrolled glaucoma or active eye disease. Patients with significant dry eye may find EVO ICL preferable to laser-based options. The only way to confirm candidacy is through a detailed evaluation with a qualified ophthalmologist who can assess your individual ocular anatomy.
EVO ICL may be a strong option for patients who have been told they are not candidates for LASIK due to thin corneas, high prescriptions, or dry eye. It is also worth exploring for patients who prefer a procedure that does not permanently alter corneal tissue. Younger patients with stable, high myopia frequently ask “am I a candidate for EVO ICL?” after feeling limited by glasses and contact lenses. To compare vision correction approaches, you may find our overview of LASIK eye surgery in New Jersey a helpful resource when preparing for your consultation.
Your candidacy appointment at Eye Care Physicians & Surgeons of New Jersey will include a comprehensive series of diagnostic measurements. These typically include corneal topography, anterior chamber depth analysis, pupil size measurement, a full refraction assessment, and an evaluation of your overall ocular health. Our practice uses advanced diagnostic technology to generate precise data that informs the surgical plan. You should plan for your pupils to be dilated during this visit, so arranging transportation home is recommended. Completing your patient intake forms before your appointment can help streamline the process.
The EVO ICL procedure is typically completed in approximately 20 to 30 minutes per eye, though patients should plan for a longer overall appointment to account for pre-procedure preparation and post-procedure monitoring. The lens is inserted through a small incision that generally does not require sutures. The procedure is performed in an outpatient surgical setting, and most patients are able to return home the same day. The brief procedural time is one reason many patients find EVO ICL a manageable option within their schedule.
EVO ICL is intended as a long-term vision correction solution. The lens is designed to remain in place indefinitely, though it can be removed or replaced by a qualified surgeon if circumstances change, such as the development of a significant cataract or a major shift in prescription. Results from EVO ICL may be stable over many years; however, the natural aging process of the eye, including the eventual development of presbyopia, is separate from the lens itself. Individual results may vary, and your ophthalmologist will discuss realistic expectations during your consultation.
Yes. Eye Care Physicians & Surgeons of New Jersey welcomes patients from throughout South Jersey and the greater Philadelphia metro area, including neighboring communities such as Cherry Hill, Voorhees, Marlton, Moorestown, and beyond. Our location in Haddonfield, NJ, is easily accessible from major roadways throughout the region. Patients who have been asking “am I a candidate for EVO ICL?” and have not yet found a specialized ophthalmology practice close to home are encouraged to reach out to our team to discuss evaluation scheduling.
Eye Care Physicians & Surgeons of New Jersey is a multi-specialty ophthalmology practice where board-certified surgeons, certified by the American Board of Ophthalmology and affiliated with the American Academy of Ophthalmology, provide care from initial evaluation through post-procedure follow-up. Rather than directing patients to outside providers at different stages of care, our practice manages your full continuum of eye health in one location. This includes access to advanced diagnostic imaging and surgical technology. You can read more about patient experiences on our New Jersey patient testimonials page.
The cost of EVO ICL is influenced by several factors, including the complexity of your prescription, the technology used during your evaluation and procedure, and the level of follow-up care included in your surgical plan. EVO ICL is generally considered an elective procedure and is typically not covered by insurance, though some plans may cover the pre-surgical evaluation portion. Financing options may be available to help manage the investment; we encourage prospective patients to ask about these options during their consultation at our Haddonfield office.
EVO ICL has received FDA approval for the correction of myopia and is supported by clinical data spanning more than two decades of use globally. As with any surgical procedure, there are potential risks and considerations, including the possibility of elevated eye pressure, halos, or glare, particularly in low-light conditions. Patients with a history of glaucoma or elevated intraocular pressure require careful evaluation before proceeding. Our board-certified ophthalmologists conduct a thorough review of each patient’s eye health history to assess suitability and discuss any concerns transparently before any decision is made.
Patients in Haddonfield, NJ, and surrounding South Jersey communities choose Eye Care Physicians & Surgeons of New Jersey because of the practice’s depth of expertise across the full spectrum of ophthalmologic care. Our board-certified surgeons bring extensive experience in both medical and surgical eye care, offering patients access to advanced diagnostic technology and individualized treatment planning under one roof. From your first candidacy evaluation to your post-procedure follow-up visits, our team is committed to continuity of care and transparent communication. Whether you are exploring EVO ICL, comparing it to LASIK in New Jersey, or managing another eye health concern, our physicians are dedicated to helping you make a well-informed decision.
If you have been asking “am I a candidate for EVO ICL?” and are ready to find out, Eye Care Physicians & Surgeons of New Jersey is here to provide expert answers. Our board-certified ophthalmologists serve patients throughout Haddonfield and the greater New Jersey region with advanced diagnostics and personalized surgical care. Contact our practice today to request your EVO ICL candidacy consultation.
THANKS FOR YOUR INTEREST! Our doctors and staff are devoted to our patients and to the commitment of providing quality patient care on all levels.
We encourage your feedback, please feel free to send us a message using the following contact form.
